ERANET on Translational Cancer Research (TRANSCAN) launches its first joint transnational call for proposals.
28 December 2011
Austria
The ERA-NET on Translational Cancer Research (TRANSCAN) has launched its first joint transnational call for proposals on: "Validation of biomarkers for personalised cancer medicine".
The TRANSCAN first joint transnational call for proposals (JTC 2011) aims at developing transnational innovative projects in oncology, clearly oriented towards a rapid application of new and more selective and effective tools and strategies for the prevention, diagnosis, early detection, and therapy of neoplastic diseases.
Transnational research proposals addressing the topic of the call must cover at least one of the following areas, which are equal in relevance for this call: prevention; early detection; diagnosis; prediction of response or resistance to treatment; prediction of treatment toxicity.
The research projects submitted within this call should fall into one of the following categories:
•bench-to-bedside studies, stemming from previous laboratory and/or early phase clinical investigations;
•bedside-to-bench studies, stemming from advanced clinical investigations.
In all cases, the research projects should clearly aim at the validation of previously identified candidate biomarkers or of their novel and/or combined use.
The research proposals should also be built on an effective, multidisciplinary and multi-professional collaboration between academic, clinical, epidemiological or public health research teams and industry. The research teams within a consortium should include investigators of all scientific disciplines, research areas and expertises necessary to achieve the proposed objectives. The sharing of relevant results, data sets and/or resources within international research consortia will be a prerequisite for funding.
There will be a two-stage submission procedure for joint applications: pre-proposals and full proposals. Both types of proposals must be written in English and must be submitted to the Joint Call Secretariat by the coordinator. Pre-proposals and full proposals should strictly follow the rules described in the Guidelines for Applicants.
For more information, please consult the Call Text and the Guidelines for Applicants on: http://www.transcanfp7.eu/transcan/mod/resource/view.php?id=45(opens in new window)
The following funding organisations from fifteen countries from the European Research Area have agreed to fund the joint call for multinational research projects in this area.
•Austrian Science Fund (FWF), Austria
•Research Foundation Flanders (FWO), Belgium
•National Cancer Institute (INCa), France
•Federal Ministry of Education and Research (BMBF), Germany
•General Secretariat for Research and Technology, Ministry of Education, Life Long Learning and Religious Affairs (GSRT), Greece
•Chief Scientist Office of the Ministry of Health (CSO-MOH), Israel
•Ministry of Health (MoH), Italy
•Latvian Academy of Science (LAS), Latvia
•National Research Fund (FNR), Luxembourg
•National Centre for Research and Development (NCBiR), Poland
•Institute of Oncology (IOB), Romania
•Slovak Academy of Sciences (SAS), Slovakia
•Ministry of Higher Education, Science and Technology (MHEST), Slovenia
•Institute of Health Carlos III (ISCIII), Spain
•Scientific and Technological Research Council of Turkey (TÜBITAK), Turkey
The call will be conducted simultaneously by the funding organisations in their respective countries and coordinated centrally by the Joint Call Secretariat (JCS).
Pre-proposals must be submitted to the electronic submission system of the Joint Call Secretariat not later than 10 February 2012, at 5 p.m. (Central European Time).
The TRANSCAN first joint transnational call for proposals (JTC 2011) aims at developing transnational innovative projects in oncology, clearly oriented towards a rapid application of new and more selective and effective tools and strategies for the prevention, diagnosis, early detection, and therapy of neoplastic diseases.
Transnational research proposals addressing the topic of the call must cover at least one of the following areas, which are equal in relevance for this call: prevention; early detection; diagnosis; prediction of response or resistance to treatment; prediction of treatment toxicity.
The research projects submitted within this call should fall into one of the following categories:
•bench-to-bedside studies, stemming from previous laboratory and/or early phase clinical investigations;
•bedside-to-bench studies, stemming from advanced clinical investigations.
In all cases, the research projects should clearly aim at the validation of previously identified candidate biomarkers or of their novel and/or combined use.
The research proposals should also be built on an effective, multidisciplinary and multi-professional collaboration between academic, clinical, epidemiological or public health research teams and industry. The research teams within a consortium should include investigators of all scientific disciplines, research areas and expertises necessary to achieve the proposed objectives. The sharing of relevant results, data sets and/or resources within international research consortia will be a prerequisite for funding.
There will be a two-stage submission procedure for joint applications: pre-proposals and full proposals. Both types of proposals must be written in English and must be submitted to the Joint Call Secretariat by the coordinator. Pre-proposals and full proposals should strictly follow the rules described in the Guidelines for Applicants.
For more information, please consult the Call Text and the Guidelines for Applicants on: http://www.transcanfp7.eu/transcan/mod/resource/view.php?id=45(opens in new window)
The following funding organisations from fifteen countries from the European Research Area have agreed to fund the joint call for multinational research projects in this area.
•Austrian Science Fund (FWF), Austria
•Research Foundation Flanders (FWO), Belgium
•National Cancer Institute (INCa), France
•Federal Ministry of Education and Research (BMBF), Germany
•General Secretariat for Research and Technology, Ministry of Education, Life Long Learning and Religious Affairs (GSRT), Greece
•Chief Scientist Office of the Ministry of Health (CSO-MOH), Israel
•Ministry of Health (MoH), Italy
•Latvian Academy of Science (LAS), Latvia
•National Research Fund (FNR), Luxembourg
•National Centre for Research and Development (NCBiR), Poland
•Institute of Oncology (IOB), Romania
•Slovak Academy of Sciences (SAS), Slovakia
•Ministry of Higher Education, Science and Technology (MHEST), Slovenia
•Institute of Health Carlos III (ISCIII), Spain
•Scientific and Technological Research Council of Turkey (TÜBITAK), Turkey
The call will be conducted simultaneously by the funding organisations in their respective countries and coordinated centrally by the Joint Call Secretariat (JCS).
Pre-proposals must be submitted to the electronic submission system of the Joint Call Secretariat not later than 10 February 2012, at 5 p.m. (Central European Time).